🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
As optimal tolerance is the key for developing new treatments for the very ...
Status
Active Not Recruiting
Location
Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik
Start Date
2021-10-20
Trial ID
NCT04891809
Treatments Being Tested
This research study is investigating the safety and effectiveness of using ...
Status
Recruiting
Location
University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center
Start Date
2022-02-18
Trial ID
NCT05145400
Treatments Being Tested
Primary Objective: To assess the effectiveness, in terms of overall respon...
Status
Completed
Location
University of Arkansas Medical Sciences Site Number : 8400021
Start Date
2020-08-13
Trial ID
NCT04458831
Treatments Being Tested
This research is testing whether the investigational drug isatuximab is saf...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2021-07-13
Trial ID
NCT04653246
Treatments Being Tested
Primary Objectives: * To evaluate the safety and tolerability of the combi...
Status
Completed
Location
University of Colorado-Site Number:8400001
Start Date
2018-02-21
Trial ID
NCT03194867
Treatments Being Tested
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795
Primary Objectives: * VCDI cohort: * To determine the maximum tolerated...
Status
Completed
Location
Investigational Site Number : 250002
Start Date
2015-09-30
Trial ID
NCT02513186
Treatments Being Tested
This is an investigator-initiated (IIS), phase 2, prospective, open-label, ...
Status
Unknown
Location
General Hospital of Athens "Evangelismos"
Start Date
2022-05
Trial ID
NCT05298683
A phase 2 study of venetoclax in combination with isatuximab and dexamethas...
Status
Recruiting
Location
Berenson Cancer Center
Start Date
2024-06-20
Trial ID
NCT06115135
Treatments Being Tested
The planned trial offers treatment cohorts for patients with full cytologic...
Status
Recruiting
Location
University Hospital Augsburg, II. Medizinischen Klinik, Hämatologie, internistische Onkologie und Hämostaseologie
Start Date
2024-10-22
Trial ID
NCT06648889
Treatments Being Tested